Related references
Note: Only part of the references are listed.Heterogeneity of CTC contributes to the organotropism of breast cancer
Tao Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
Olga E. Savelieva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Intravasation as a Key Step in Cancer Metastasis
M. V. Zavyalova et al.
BIOCHEMISTRY-MOSCOW (2019)
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis
Xiao Liu et al.
SCIENCE ADVANCES (2019)
Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance
Shaolei Lu et al.
BMC CANCER (2019)
Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
Aleksandra Markiewicz et al.
CANCERS (2019)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Francois-Clement Bidard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Francois-Clement Bidard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer
N. V. Sankpal et al.
ONCOGENE (2017)
Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications
Xiao-Xiang Jie et al.
ONCOTARGET (2017)
Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues
Edwin R. Parra et al.
SCIENTIFIC REPORTS (2017)
Circulating tumor cells in breast cancer patients
B. Bystricky et al.
NEOPLASMA (2016)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival
Anne Grosse-Wilde et al.
PLOS ONE (2015)
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
Brigitte Rack et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
A pooled analysis of the prognostic relevance of circulating tumor cells in early breast cancer
W. J. Janni et al.
CANCER RESEARCH (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
R. Y-J Huang et al.
CELL DEATH & DISEASE (2013)
Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer
Cheng-Wei Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci et al.
LANCET ONCOLOGY (2012)
Molecular characterization of TGFβ-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells
Linsey E. Lindley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility
Silvia Giampieri et al.
NATURE CELL BIOLOGY (2009)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
